0
     

Report Added
Report already added
Global DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Region: Trend Forecast and Growth Opportunity

Global DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Region: Trend Forecast and Growth Opportunity

Global DNA sequencing market will reach $52,278.1 million by 2031, growing by 15.4% annually over 2021-2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA sequencing for animal & plant reproduction.

Highlighted with 81 tables and 89 figures, this 164-page report “Global DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global DNA sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global DNA sequencing market in every aspect of the classification from perspectives of Offering, Sequencing Type, Technology, Application, End User, and Region.

Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Instruments
•Consumables
•Sequencing Services

Based on Sequencing Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Sanger Sequencing
•Next Generation Sequencing
•Other Sequencing Types

By Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Sequencing by Synthesis
•Ion Semiconductor Sequencing
•Chain Termination Sequencing
•Pyrosequencing
•Sequencing by Ligation (SBL)
•Single-Molecule Real-Time Sequencing (SMRT)
•Nanopore Sequencing
•Other Technologies

By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Biomarker Discovery
•Diagnostics
•Personalized Medicine
•Reproductive Health
•Forensics
•Other Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Academics and Research Organizations
•Pharmaceutical and Biotechnology Companies
•Hospitals & Clinics
•Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
•North America (U.S., Canada, and Mexico)
•Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
•APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
•South America (Brazil, Chile, Argentina, Rest of South America)
•MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Offering, Sequencing Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
Agilent Technologies Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
Illumina Inc.
Merck KGaA
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction9
1.1 Industry Definition and Research Scope9
1.1.1 Industry Definition9
1.1.2 Research Scope10
1.2 Research Methodology13
1.2.1 Overview of Market Research Methodology13
1.2.2 Market Assumption14
1.2.3 Secondary Data14
1.2.4 Primary Data14
1.2.5 Data Filtration and Model Design15
1.2.6 Market Size/Share Estimation16
1.2.7 Research Limitations17
1.3 Executive Summary18
2 Market Overview and Dynamics21
2.1 Market Size and Forecast21
2.1.1 Impact of COVID-19 on World Economy22
2.1.2 Impact of COVID-19 on the Market24
2.2 Major Growth Drivers26
2.3 Market Restraints and Challenges33
2.4 Emerging Opportunities and Market Trends36
2.5 Porter’s Fiver Forces Analysis40
3 Segmentation of Global Market by Offering44
3.1 Market Overview by Offering44
3.2 Instruments46
3.3 Consumables47
3.4 Sequencing Services48
4 Segmentation of Global Market by Sequencing Type49
4.1 Market Overview by Sequencing Type49
4.2 Sanger Sequencing51
4.3 Next Generation Sequencing52
4.4 Other Sequencing Types53
5 Segmentation of Global Market by Technology54
5.1 Market Overview by Technology54
5.2 Sequencing by Synthesis56
5.3 Ion Semiconductor Sequencing57
5.4 Chain Termination Sequencing58
5.5 Pyrosequencing59
5.6 Sequencing by Ligation (SBL)60
5.7 Single-Molecule Real-Time Sequencing (SMRT)61
5.8 Nanopore Sequencing62
5.9 Other Technologies63
6 Segmentation of Global Market by Application64
6.1 Market Overview by Application64
6.2 Biomarker Discovery66
6.3 Diagnostics67
6.4 Personalized Medicine68
6.5 Reproductive Health69
6.6 Forensics70
6.7 Other Applications71
7 Segmentation of Global Market by End User72
7.1 Market Overview by End User72
7.2 Academics and Research Organizations74
7.3 Pharmaceutical and Biotechnology Companies75
7.4 Hospitals & Clinics76
7.5 Other End Users77
8 Segmentation of Global Market by Region78
8.1 Geographic Market Overview 2021-203178
8.2 North America Market 2021-2031 by Country82
8.2.1 Overview of North America Market82
8.2.2 U.S.86
8.2.3 Canada89
8.2.4 Mexico91
8.3 European Market 2021-2031 by Country93
8.3.1 Overview of European Market93
8.3.2 Germany97
8.3.3 U.K.99
8.3.4 France101
8.3.5 Spain103
8.3.6 Italy105
8.3.7 Russia107
8.3.8 Rest of European Market109
8.4 Asia-Pacific Market 2021-2031 by Country111
8.4.1 Overview of Asia-Pacific Market111
8.4.2 Japan115
8.4.3 China118
8.4.4 Australia120
8.4.5 India122
8.4.6 South Korea124
8.4.7 Rest of APAC Region126
8.5 South America Market 2021-2031 by Country128
8.5.1 Argentina131
8.5.2 Brazil133
8.5.3 Chile135
8.5.4 Rest of South America Market137
8.6 MEA Market 2021-2031 by Country138
8.6.1 UAE141
8.6.2 Saudi Arabia143
8.6.3 South Africa145
8.6.4 Other National Markets147
9 Competitive Landscape148
9.1 Overview of Key Vendors148
9.2 New Product Launch, Partnership, Investment, and M&A151
9.3 Company Profiles152
Agilent Technologies Inc.152
BGI Genomics Co., Ltd.154
Bio-Rad Laboratories Inc.155
Danaher Corporation (Integrated DNA Technologies Inc.)156
Eurofins Scientific SE157
F. Hoffmann-La Roche Ltd.158
Illumina Inc.159
Merck KGaA160
Pacific Biosciences of California Inc.161
PerkinElmer Inc.162
Thermo Fisher Scientific Inc.163
RELATED REPORTS164

List of Tables:

Table 1. Snapshot of Global DNA Sequencing Market in Balanced Perspective, 2021-203119
Table 2. World Economic Outlook, 2021-203123
Table 3. World Health Spending by Region, $ bn, 2013-202032
Table 4. Main Product Trends and Market Opportunities in Global DNA Sequencing Market36
Table 5. Global DNA Sequencing Market by Offering, 2021-2031, $ mn44
Table 6. Global DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn49
Table 7. Global DNA Sequencing Market by Technology, 2021-2031, $ mn54
Table 8. Global DNA Sequencing Market by Application, 2021-2031, $ mn64
Table 9. Global DNA Sequencing Market by End User, 2021-2031, $ mn72
Table 10. Global DNA Sequencing Market by Region, 2021-2031, $ mn79
Table 11. Leading National DNA Sequencing Market, 2021 and 2031, $ mn81
Table 12. North America DNA Sequencing Market by Country, 2021-2031, $ mn84
Table 13. U.S. DNA Sequencing Market by Offering, 2021-2031, $ mn88
Table 14. U.S. DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn88
Table 15. U.S. DNA Sequencing Market by End User, 2021-2031, $ mn88
Table 16. Canada DNA Sequencing Market by Offering, 2021-2031, $ mn90
Table 17. Canada DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn90
Table 18. Canada DNA Sequencing Market by End User, 2021-2031, $ mn90
Table 19. Mexico DNA Sequencing Market by Offering, 2021-2031, $ mn92
Table 20. Mexico DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn92
Table 21. Mexico DNA Sequencing Market by End User, 2021-2031, $ mn92
Table 22. Europe DNA Sequencing Market by Country, 2021-2031, $ mn96
Table 23. Germany DNA Sequencing Market by Offering, 2021-2031, $ mn98
Table 24. Germany DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn98
Table 25. Germany DNA Sequencing Market by End User, 2021-2031, $ mn98
Table 26. U.K. DNA Sequencing Market by Offering, 2021-2031, $ mn100
Table 27. U.K. DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn100
Table 28. U.K. DNA Sequencing Market by End User, 2021-2031, $ mn100
Table 29. France DNA Sequencing Market by Offering, 2021-2031, $ mn102
Table 30. France DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn102
Table 31. France DNA Sequencing Market by End User, 2021-2031, $ mn102
Table 32. Spain DNA Sequencing Market by Offering, 2021-2031, $ mn104
Table 33. Spain DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn104
Table 34. Spain DNA Sequencing Market by End User, 2021-2031, $ mn104
Table 35. Italy DNA Sequencing Market by Offering, 2021-2031, $ mn106
Table 36. Italy DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn106
Table 37. Italy DNA Sequencing Market by End User, 2021-2031, $ mn106
Table 38. Russia DNA Sequencing Market by Offering, 2021-2031, $ mn108
Table 39. Russia DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn108
Table 40. Russia DNA Sequencing Market by End User, 2021-2031, $ mn108
Table 41. DNA Sequencing Market in Rest of Europe by Country, 2021-2031, $ mn110
Table 42. APAC DNA Sequencing Market by Country, 2021-2031, $ mn113
Table 43. Japan DNA Sequencing Market by Offering, 2021-2031, $ mn117
Table 44. Japan DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn117
Table 45. Japan DNA Sequencing Market by End User, 2021-2031, $ mn117
Table 46. China DNA Sequencing Market by Offering, 2021-2031, $ mn119
Table 47. China DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn119
Table 48. China DNA Sequencing Market by End User, 2021-2031, $ mn119
Table 49. Australia DNA Sequencing Market by Offering, 2021-2031, $ mn121
Table 50. Australia DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn121
Table 51. Australia DNA Sequencing Market by End User, 2021-2031, $ mn121
Table 52. India DNA Sequencing Market by Offering, 2021-2031, $ mn123
Table 53. India DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn123
Table 54. India DNA Sequencing Market by End User, 2021-2031, $ mn123
Table 55. South Korea DNA Sequencing Market by Offering, 2021-2031, $ mn125
Table 56. South Korea DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn125
Table 57. South Korea DNA Sequencing Market by End User, 2021-2031, $ mn125
Table 58. DNA Sequencing Market in Rest of APAC by Country/Region, 2021-2031, $ mn127
Table 59. South America DNA Sequencing Market by Country, 2021-2031, $ mn130
Table 60. Argentina DNA Sequencing Market by Offering, 2021-2031, $ mn132
Table 61. Argentina DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn132
Table 62. Argentina DNA Sequencing Market by End User, 2021-2031, $ mn132
Table 63. Brazil DNA Sequencing Market by Offering, 2021-2031, $ mn134
Table 64. Brazil DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn134
Table 65. Brazil DNA Sequencing Market by End User, 2021-2031, $ mn134
Table 66. Chile DNA Sequencing Market by Offering, 2021-2031, $ mn136
Table 67. Chile DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn136
Table 68. Chile DNA Sequencing Market by End User, 2021-2031, $ mn136
Table 69. MEA DNA Sequencing Market by Country, 2021-2031, $ mn140
Table 70. UAE DNA Sequencing Market by Offering, 2021-2031, $ mn142
Table 71. UAE DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn142
Table 72. UAE DNA Sequencing Market by End User, 2021-2031, $ mn142
Table 73. Saudi Arabia DNA Sequencing Market by Offering, 2021-2031, $ mn144
Table 74. Saudi Arabia DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn144
Table 75. Saudi Arabia DNA Sequencing Market by End User, 2021-2031, $ mn144
Table 76. South Africa DNA Sequencing Market by Offering, 2021-2031, $ mn146
Table 77. South Africa DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn146
Table 78. South Africa DNA Sequencing Market by End User, 2021-2031, $ mn146
Table 79. Agilent Technologies Inc.: Company Snapshot152
Table 80. Agilent Technologies Inc.: Business Segmentation153
Table 81. Agilent Technologies Inc.: Product Portfolio153

Report Title: Global DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Region: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline